Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT ID: NCT05177380
Last Updated: 2022-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2022-09-30
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Facial involvement in systemic sclerosis can be assessed using the Mouth Handicap in Systemic Sclerosis (MHISS) score, a validated patient questionnaire assessing the functional and aesthetic consequences of systemic sclerosis on the face.
Although common and disabling, facial involvement is underestimated and poorly managed. Immunosuppressive and/or anti-fibrosis drugs are not very effective. Facial rehabilitation could significantly improve the mouth handicap but facial rehabilitation is not currently performed in standard care in systemic sclerosis patients.
The aim of the study is to evaluate the efficacy of a personalized rehabilitation program vs standard care in facial involvement of systemic sclerosis patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis
NCT00318188
Evaluation of Muscle Involvement in Systemic Sclerosis
NCT06051773
EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS
NCT02206672
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Personalized rehabilitation program of facial involvement in systemic sclerosis
3 sessions of 2 hours of facial rehabilitation in hospital over 2 weeks including:
* Physiotherapy with facial and endo-oral massages, self-massages, active and passive exercises of the face and mouth, tongue exercises
* Speech therapy with mobilization of the orofacial sphere applied to swallowing and speech difficulties
* Individual workshop on the theme of dry mouth, dry mouth, swallowing disorders, and oral care
* Individual therapeutic makeup workshop
* A motivational interview
* A patient notebook with a personalized protocol for self-rehabilitation of the face
* A video tutorial for self-rehabilitation of the face Facial self-rehabilitation sessions at home
Personalized rehabilitation program of facial involvement in systemic sclerosis
Personalized rehabilitation program of facial involvement in systemic sclerosis
Routine care
Delivery of a standard prescription for facial rehabilitation
Delivery of a standard prescription for facial rehabilitation
Delivery of a standard prescription for facial rehabilitation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Personalized rehabilitation program of facial involvement in systemic sclerosis
Personalized rehabilitation program of facial involvement in systemic sclerosis
Delivery of a standard prescription for facial rehabilitation
Delivery of a standard prescription for facial rehabilitation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Systemic sclerosis according to the 2013 ACR/EULAR (American College of Rheumatology) classification criteria
* Systemic sclerosis with facial involvement defined by a MHISS score \> 6
* Immunosuppressive and/or anti-fibrosis treatment stable for at least 1 month
* Subject able to understand the objectives and risks of research and to give informed consent
* Subject enrolment in the health insurance scheme
Exclusion Criteria
* Previous participation in a rehabilitation program of facial involvement
* Patient under legal protection
* Impossibility to give clear information of subject
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8072
Identifier Type: -
Identifier Source: org_study_id
2020-A03314-35
Identifier Type: OTHER
Identifier Source: secondary_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.